Fig. 3. Statin therapy is associated with a small increase in new-onset diabetes type 2. The underlying pathophysiology is not well understood. A number of different mechanisms may lead to decreased insulin sensitivity and altered β-cell function. In predisposed subjects this may induce the manifestation of type 2 diabetes. HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A.
